Cargando…

Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer’s Disease and Related Disorders

Behavioral and psychological symptoms (BPSD) are now known to be frequently associated to cognitive and functional decline in Alzheimer‘s disease and related disorders. They are present since the early stages of the disease and have negative impact on the disease process. BPSD assessment is crucial...

Descripción completa

Detalles Bibliográficos
Autores principales:	David, Renaud, Mulin, Emmanuel, Mallea, Patrick, Robert, Philippe H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033930/ https://www.ncbi.nlm.nih.gov/pubmed/27713359 http://dx.doi.org/10.3390/ph3082387

Ejemplares similares

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease
por: Cummings, J, et al.
Publicado: (2015)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
por: Iravani, Behnam, et al.
Publicado: (2022)

Network Analysis of Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Goodwin, Grace J., et al.
Publicado: (2023)

Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
por: Goodwin, Grace J., et al.
Publicado: (2023)

Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer’s disease
por: Liu, Kathy Y, et al.
Publicado: (2020)

A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer’s disease
por: Geerts, Hugo, et al.
Publicado: (2013)

Neuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease
por: Suárez-González, Aida, et al.
Publicado: (2016)

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017)

Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
por: Schaffer Aguzzoli, Cristiano, et al.
Publicado: (2023)

Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer’s disease
por: Hall, James R, et al.
Publicado: (2015)

Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer’s disease
por: Allegri, Ricardo F, et al.
Publicado: (2006)

Neuropsychiatric symptoms of the elderly with Alzheimer's disease and the family caregivers' distress
por: Storti, Luana Baldin, et al.
Publicado: (2016)

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
por: Benhabib, Hadas, et al.
Publicado: (2013)

Neuropsychiatric symptoms as the main determinant of caregiver burden in Alzheimer’s disease
por: Kochhann, Renata, et al.
Publicado: (2011)

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
por: Lanctôt, Krista L., et al.
Publicado: (2017)

Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease
por: Hwang, Inha, et al.
Publicado: (2017)

Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease
por: Li, Kaicheng, et al.
Publicado: (2022)

Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer’s disease patients for distress on the Neuropsychiatric Inventory (NPI)
por: Godinho, Cláudia, et al.
Publicado: (2008)

The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders
por: König, Alexandra, et al.
Publicado: (2015)

Measuring neuropsychiatric symptoms in patients with early cognitive decline using speech analysis
por: König, Alexandra, et al.
Publicado: (2021)

Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial
por: Stella, Florindo, et al.
Publicado: (2011)

Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia
por: Liew, Tau Ming
Publicado: (2020)

Efficacy of serious exergames in improving neuropsychiatric symptoms in neurocognitive disorders: Results of the X‐TORP cluster randomized trial
por: Robert, Philippe, et al.
Publicado: (2021)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
por: Dang, Mingxi, et al.
Publicado: (2022)

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
por: Pless, Andrew, et al.
Publicado: (2023)

Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
por: Sampedro, Frederic, et al.
Publicado: (2022)

The Relationship between Neuropsychiatric Symptoms and Default-Mode Network Connectivity in Alzheimer’s Disease
por: Lee, Jung Suk, et al.
Publicado: (2020)

White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s disease
por: Misquitta, Karen, et al.
Publicado: (2020)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

The Relationship Between Neuropsychiatric Symptoms, Nighttime Behaviors, and Alzheimer’s Disease CSF Biomarkers
por: Zhang, Meina, et al.
Publicado: (2021)

The Relationship Between Neuropsychiatric Symptoms, Nighttime Behaviors, and Alzheimer’s Disease CSF Biomarkers
por: Zhang, Meina, et al.
Publicado: (2021)

Physical exercise is effective for neuropsychiatric symptoms in Alzheimer's disease: a systematic review
por: Mendonça, Dayanne Christine Borges, et al.
Publicado: (2021)

Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2022)

Neuropsychiatric Symptoms of Alzheimer’s Disease in Down Syndrome and Its Impact on Caregiver Distress
por: Fonseca, Luciana Mascarenhas, et al.
Publicado: (2021)

Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
por: Ouanes, Sami, et al.
Publicado: (2022)

Associations between neuropsychiatric symptoms and incident Alzheimer’s dementia in men versus women
por: Liampas, Ioannis, et al.
Publicado: (2022)

Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: Erratic symptoms or scores?
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Measuring neuropsychiatric symptoms in early dementia patients using speech analysis
por: König, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oht30neb87rcldakces2ph59oj